Comparative methods of toxicity testing: Consensus document following an International Life Sciences Institute-ILSI Europe workshop held in May 1995

Food and Chemical Toxicology

Volumn 34, Issue 2, 1996, Pages 183-192

  Huggett, A C ^a   Schilter, B ^a   Roberfroid, M ^b   Antignac, E ^c   Koeman, J H ^d  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; PARACETAMOL; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

CARCINOGEN TESTING; CONFERENCE PAPER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; NONHUMAN; SAFETY; TOXICITY TESTING;

ACETAMINOPHEN; AFLATOXIN B1; ANIMALS; CARCINOGENS; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LETHAL DOSE 50; LIVER; RISK ASSESSMENT; TOXICOLOGY;

EID: 0029869227     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-6915(95)00098-4     Document Type: Note

References (34)

1. Ashby J., Brady A., Elcombe C. R., Elliot B. M., Ishmal J., Odum J., Tugwood J. D., Kettle S. and Purchase I. F. H. (1994) Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human and Experimental Toxicology 13, Suppl. 2, S1-S117.
2. Barratt M. D., Castell J. V., Chamberlain M., Combes R. D., Dearden J. C., Fentem J. H., Gerner I., Giuliani A., Gray T. J. B., Livingstone D. J., McLean Provan W., Rutten F. A. J. J. L., Verhaar H. J. M. and Zbinden P. (1995) The Integrated Use of Alternative Approaches for Predicting Toxic Hazard. The Report and Recommendations of ECVAM Workshop 8. ATLA 23, 410-429.
3. Beliles R., Salinas J. A. and Kluwe W. M. (1989) A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments. Drug Metabolism Reviews 21, 3-12.
4. Committee on Risk Assessment of Hazardous Air Pollutants, National Research Council (1994) Science and Judgement in Risk Assessment. National Academy Press, Washington, DC.
5. Csanady G. A., Guengerich F. P. and Bond J. A. (1992) Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
6. Davidson D. G. D. and Eastham W. N. (1966) Acute liver necrosis following overdose of paracetamol. British Medical Journal 2, 497-499.
7. Davis D. C., Potter W. Z., Jollow D. J. and Mitchell J. R. (1974) Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after paracetamol. Life Sciences 14, 2099-2109.
8. Dwivedi R. S., Alvares K., Nemali M. R., Subbarao V., Reddy M. K., Usman M. I., Rademaker A. W., Reddy J. K. and Roa M. S. (1989) Comparison of the peroxisome proliferator-induced pleiotropic response in the liver of nine strains of mice. Toxicologic Pathology 17, 16-26.
9. Eaton D. L. and Gallagher E. P. (1994) Mechanism of aflatoxin carcinogenesis. Annual Review of Toxicology 34, 135-172.
10. FDA (1982) Toxicological Principles for Safety Assessment of Direct Food Additives and Colour Additives used in Food. Food and Drug Administration, Bureau of Foods, National Technical Information Service, Springfield, VA.
11. FDA (1993) Toxicological Principles for Safety Assessment of Direct Food Additives and Colour Additives used in Food. "Red Book II" (draft). Food and Drug Administration, Center for Food Safety and Applied Nutrition. Washington, DC.
12. Gariot P., Barrat E., Mejean L., Pointel J. P., Drouin O. and Debry G. (1983) Fenofibrate and human liver - lack of proliferation of peroxisomes. Archives of Toxicology 53, 151-163.
13. Goldenthal E. I. (1971) A compilation of LD50 values in newborn and adult animals. Toxicology and Applied Pharmacology 18, 185-207.
14. Hathaway S. C. (1993) Risk assessment procedures used by the Codex Alimentarius Commission and its subsidiary and advisory bodies. Food Control 4, 189-201.
15. IARC (1993) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 56. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Amines and Mycotoxins. International Agency for Research on Cancer, Lyon.
16. IPCS/WHO (1992) International Programme on Chemical Safety/World Health Organization. Diethylhexylphthalate. Environmental Health Criteria 131, 1-141.
17. Jonker D. and Til H. P. (1995) Human diets cooked by microwave or conventionally: comparative sub-chronic (13-wk) toxicity study in rats. Food and Chemical Toxicology 33, 245-256.
18. Krishnan V. and Safe S. (1993) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicology and Applied Pharmacology 120, 55-61.
19. Lake B. G. (1995) Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annual Review of Pharmacology and Toxicology 35, 483-507.
20. Lake B. G., Gray T. J. B., Foster J. R., Stubberfield, C. R. and Gangolli S. D. (1984) Comparative studies on di(2-ethylhexyl)phthalate-induced peroxisome proliferation in the rat and hamster. Toxicology and Applied Pharmacology 72, 46-60.
21. Lake B. G., Gray T. J. B. and Gangolli S. D. (1986) Hepatic effects of phthalate esters and related compounds - in vivo and in vitro correlations. Environmental Health Perspectives 67, 283-290.
22. Lu, F. C. (1988) Acceptable daily intake: inception, evolution, and application. Regulatory Toxicology and Pharmacology 8, 45-60.
23. Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R. and Brodie B. B. (1973) Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 187, 211-217.
24. Moss E. J. and Neal G. E. (1985) The metabolism of aflatoxin B1 by human liver. Biochemical Pharmacology 34, 813-821.
25. NTP (1982) Carcinogenesis Bioassay of Di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 Mice (feed study). Technical Report Series 217. National Toxicology Program.
26. OECD (1987) OECD Guidelines for Testing of Chemicals. Organisation for Economic Cooperation and Development, Paris.
27. Pariza M. W. (1992) Risk assessment. Critical Reviews in Food Science and Nutrition 31, 205-209.
28. Ramsdell H. S. and Eaton D. L. (1990) Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Research 50, 645-620.
29. Smith-Oliver T. and Butterworth B. E. (1987) Correlation of carcinogenic potential of di(2-ethylhexyl)phthalate (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutation Research 188, 21-28.
30. Sobels, F. H. (1982) Parallelogram: an indirect approach for the assessment of genetic risks from chemical mutagens, human population monitoring and genetic risk assessment. Progress in Mutation Research 3, 323-328.
31. Starmer G. A., McLean S. and Thomas J. (1971) Analgesic potency and acute toxicity of substituted anilides and benzamides. Toxicology and Applied Pharmacology 19, 20-28.
32. Törrönen R., Karenlampi S. and Pelkonen K. (1994) Hepa-1 enzyme induction assay as an in vitro indicator of the CYP1A1-inducing potencies of laboratory rodent diets in vivo. Life Sciences 55, 1945-1954.
33. USCPSC (1985) Report to the US Consumer Product Safety Commission by the Chronic Advisory Panel on Di(2-ethylhexyl)phthalate (DEHP). US Consumer Product Safety Commission, Washington, DC.
34. WHO (1994) Assessing Human Health Risks of Chemicals. Derivation of Guidance Values for Health-based Exposure Limits. Environmental Health Criteria Vol. 170. WHO International Programme on Chemical Safety (IPCS). World Health Organization, Geneva.